Effect of beta blockade on natriuretic peptides and copeptin in elderly patients with heart failure and preserved or reduced ejection fraction: Results from the CIBIS-ELD trial-Reference-Cited by-同舟云学术

Effect of beta blockade on natriuretic peptides and copeptin in elderly patients with heart failure and preserved or reduced ejection fraction: Results from the CIBIS-ELD trial

Published:2012-01 Issue:1-2 Volume:45 Page:117-122
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Loncar Goran,von Haehling Stephan,Tahirovic Elvis,Inkrot Simone,Mende Meinhard,Sekularac Nikola,Lainscak Mitja,Apostolovic Svetlana,Putnikovic Biljana,Edelmann Frank,Wachter Rolf,Dimkovic Sinisa,Waagstein Finn,Gelbrich Götz,Düngen Hans-Dirk

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference39 articles.

1. Trends in prevalence and outcome of heart failure with preserved ejection fraction;Owan;N Engl J Med,2006

2. Outcome of heart failure with preserved ejection fraction in a population-based study;Bhatia;N Engl J Med,2006

3. Effect of Beta-blocker therapy on rehospitalization rates in women versus men with heart failure and preserved ejection fraction;Farasat;Am J Cardiol,2010

4. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma;Morgenthaler;Clin Chem,2004

5. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial;Maisel;J Am Coll Cardiol,2010

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress of electrochemistry in detecting markers of cardiovascular disease;Microchemical Journal;2023-12

2. Role of copeptin in diagnosis and outcome prediction in patients with heart failure: a systematic review and meta-analysis;Biomarkers;2022-09-15

3. Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases;Frontiers in Cardiovascular Medicine;2022-07-04

4. Angiotensin Receptor Neprilysin Inhibitors in HFrEF: Is This the First Disease Modifying Therapy Drug Class Leading to a Substantial Reduction in Diuretic Need?;International Journal of Heart Failure;2021

5. The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome;Endocrine Connections;2020-07